VK2809 shows potential in treating NASH-related fibrosis in early study
Results from a mouse study of nonalcoholic steatohepatitis were promising for Viking Therapeutics' oral therapy VK2809, now also in a Phase 2 trial.
Jose Marques Lopes, PhD, Managing Science Editor — 
Articles by Jose Marques Lopes
Changes in Gut Microbiota Can Aid Liver and Work to Counter Obesity, Mouse Study Shows
Dysbiosis, an imbalance in the proportion and activity of bacterial groups of the gut microbiota, can actually aid in liver metabolism and protect the body against…
Diabetes Increases Risk of Liver Disease, Regardless of Weight, Study Indicates
Type 2 diabetes increases the risk of a person getting a severe liver disease, including cancer, regardless of their body mass index (BMI) reading, research…
Focused Ultrasound Shows Promise in Destroying Liver Tumors, Project Shows
Focused ultrasound appears to be able to selectively destroy liver tumors, new research from an EU project shows. Preliminary results of this new method, developed…